- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.07. | Focus collaborates with Glucotrack on implantable CBGM | 1 | MassDevice | ||
| 01.07. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.06. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS | 1 | GlobeNewswire (USA) | ||
| 13.06. | GlucoTrack, Inc.: GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR | 1 | GlobeNewswire (USA) | ||
| 13.06. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | GlucoTrack, Inc.: GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE | 1 | GlobeNewswire (USA) | ||
| 06.06. | Glucotrack has more data backing implantable glucose monitor, plans for human trials this year | 1 | MassDevice | ||
| 05.06. | Glucotrack Static on Study | 2 | Baystreet.ca | ||
| 05.06. | GlucoTrack, Inc.: Glucotrack Announces 90-day Preclinical Study Results That Demonstrate Sustained Accuracy Of Its Implantable Continuous Blood Glucose Monitor | 95 | GlobeNewswire (Europe) | Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose monitor offers the potential for simplified, discreet... ► Artikel lesen | |
| 24.05. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | GlucoTrack, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.05. | GlucoTrack, Inc.: Glucotrack Announces Reverse Stock Split | 98 | GlobeNewswire (Europe) | 1-for-5 reverse stock split to become effective as of the opening of trading onMay 20, 2024 Rutherford, NJ, May 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company")... ► Artikel lesen | |
| 02.05. | GlucoTrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.04. | GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying | 2 | Benzinga.com | ||
| 22.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT | 1 | GlobeNewswire (USA) | ||
| 16.04. | Glucotrack expands CGM tech to spinal epidural space | 1 | MassDevice | ||
| 16.04. | Glucotrack announces expansion into epidural glucose monitoring solutions | 1 | Seeking Alpha | ||
| 16.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING | 1 | GlobeNewswire (USA) | ||
| 02.04. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR | 3 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 43,360 | +2,12 % | Eckert&Ziegler-Aktie leicht im Minus (43,00 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Eckert&Ziegler derzeit im Minus. Zuletzt zahlten Investoren für die Aktie 43,00 Euro. Ein Wertverlust in Höhe von 1,54 Euro müssen derzeit die... ► Artikel lesen | |
| SERNOVA | 0,180 | -2,60 % | Sernova beruft Jonathan Rigby in sein Board of Directors | London, Ontario; Boston, Massachusetts, den 28. Mai 2024 - Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FWB/XETRA: PSH), ein Biotechnologieunternehmen in der
klinischen Phase, das sich auf die Entwicklung... ► Artikel lesen | |
| SYNLAB | 10,960 | +0,18 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| NUGEN MEDICAL DEVICES | 0,083 | -3,02 % | Breaking News: NuGen Medical - unfassbarer Rekordauftrag! | ||
| EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 0,337 | +6,66 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine | BOULDER, CO / ACCESSWIRE / July 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,060 | +2,91 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| QUIDELORTHO | 35,200 | -0,56 % | S&P Dow Jones Indices: Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 | NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:
Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp.... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| UNIDOC HEALTH | 0,426 | -0,47 % | UniDoc Health Corp.: UniDoc Receives Purchase Order from HP Inc. for 10 AI-Equipped H3 Health Cubes | -- eHealth solution to be deployed in Europe
VANCOUVER, BC, June 17, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 133,90 | -0,15 % | Quest Diagnostics Q2 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) released earnings for second quarter that decreased from last year but beat the Street estimates.The company's bottom line totaled $229 million... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,588 | +1,15 % | Aktien New York Ausblick: Weitere Tech-Rekorde - Nasdaq 100 mit 20 000 Punkten | NEW YORK (dpa-AFX) - Nach dem Feiertag zur Wochenmitte dürften die US-Aktienmärkte am Donnerstag gut behauptet eröffnen. Dabei sollten die Technologiewerte - allen voran die Halbleiterbranche - an... ► Artikel lesen | |
| VERU | 0,843 | -3,33 % | Veru Inc.: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program | --Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific... ► Artikel lesen | |
| SENSEONICS | 0,430 | +7,32 % | Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results | GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,360 Euro und damit -2,86 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.
